Citadel Advisors
AEMD icon

Citadel Advisors’s Aethlon Medical AEMD Stock Holding History

Citadel Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,902
Closed -$71.2K – 12537
2025
Q3 		$71.2K Buy
+1,902
New +$110K ﹤0.01% 12028
2025
Q2 		– Sell
-35
Closed -$5.06K – 12347
2025
Q1 		$5.06K Buy
+35
New +$8.15K ﹤0.01% 13843
2022
Q4 		– Sell
-31
Closed -$72K – 14823
2022
Q3 		$72K Buy
+31
New +$134K ﹤0.01% 11351
2022
Q1 		– Sell
-9
Closed -$66K – 13468
2021
Q4 		$66K Buy
+9
New +$102K ﹤0.01% 13081
2021
Q2 		– Sell
-4
Closed -$29K – 13583
2021
Q1 		$29K Buy
+4
New +$38.5K ﹤0.01% 13033
2019
Q4 		– Hold
0
– -$2K – 9039
2019
Q3 		– Sell
-1
Closed -$17.3K – 9080
2019
Q2 		$30K Buy
+1
New +$33.5K ﹤0.01% 8872
2019
Q1 		– Hold
0
– – – 9047
2018
Q4 		– Hold
0
– -$17K – 9021
2018
Q3 		– Hold
0
– – – 9035
2017
Q4 		– Hold
0
– -$19K – 7915
2017
Q3 		– Hold
0
– – – 7365

Other funds holding AEMD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Citadel Advisors's AEMD Position: Q4 2025 in Review

Citadel Advisors sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 1,902 shares — an estimated $71.2K sold.

Citadel Advisors first reported a position in AEMD in Q2 2019 and held it in 6 quarters. The position peaked at $72K in Q3 2022. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

  • Citadel Advisors reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 1,902 Aethlon Medical shares in Q4 2025, an estimated $71.2K.
  • Citadel Advisors first reported a position in Aethlon Medical in Q2 2019 and held it in 6 quarters.
  • Citadel Advisors's Aethlon Medical position peaked at $72K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.